一级亲属患非髓样甲状腺癌个体中甲状腺结节与甲状腺癌的患病率:基于超声筛查的横断面研究
该横断面研究纳入1176名有一级亲属确诊非髓样甲状腺癌的无症状个体,2009至2018年间行颈部超声筛查,可疑结节行细针穿刺活检。结果显示甲状腺结节患病率42.5%,甲状腺癌患病率0.9%;家族中≥3例确诊者的受检者甲状腺癌患病率12.5%,高于1例者1.7%和2例者1.9%。
要点
- 超声筛查1176名非髓样甲状腺癌患者一级亲属,甲状腺结节患病率42.5%,甲状腺癌患病率0.9%。
- 家族中≥3例非髓样甲状腺癌确诊者,受检者甲状腺癌患病率12.5%,高于1例者1.7%(P=0.01,OR 7.99)。
- 家族中1、2、≥3例确诊者的受检者甲状腺结节患病率分别为61.8%、75.7%、66.7%(P=0.03)。
核心结论
- 对确诊非髓样甲状腺癌患者的一级亲属行超声筛查,可能发现较高的甲状腺结节患病率和较低的甲状腺癌患病率。
- 家族中筛查前已有至少3例非髓样甲状腺癌确诊者的受检者,甲状腺癌患病率显著更高,作者认为此类家族性水平的家系可能需要更密切的监测。
研究设计与样本
- 横断面研究,纳入同意参与的无症状个体(10岁及以上),其一级亲属确诊非髓样甲状腺癌。
- 2009年至2018年间对入组者行颈部超声检查,按现行指南认为可疑的结节行细针穿刺活检进行细胞学检查。
- 筛查人群共1176人(中位年龄42岁[26-56],女性650人,占55.3%),来自473个家系;入门时346个家系有1例确诊非髓样甲状腺癌,103个家系有2例,24个家系有3例或以上。
主要发现
- 筛查发现甲状腺结节500例(42.5%;CI 39.7-45.4%)。
- 500例结节中97例(19.4%;CI 16.2-23.1%)行细针穿刺活检。
- 全人群仅诊断甲状腺癌11例(0.9%;CI 0.5-1.7%)。
- 家族中≥3例确诊者的受检者甲状腺癌患病率为12.5%(3/24),高于1例者1.7%(6/346;P=0.01,OR 7.99;CI 1.21-40.75)和2例者1.9%(2/103;P=0.05,OR 7.05;CI 0.76-89.44)。
- 家族中1、2、≥3例确诊者的受检者甲状腺结节患病率分别为61.8%(CI 56.6-66.8%)、75.7%(CI 66.6-83%)、66.7%(CI 46.7-82%)(P=0.03)。
临床怎么用
- 作者认为,对确诊非髓样甲状腺癌患者的一级亲属行超声筛查,可能发现较高的甲状腺结节患病率和较低的甲状腺癌患病率。
- 作者认为,家族中筛查前已有至少3例非髓样甲状腺癌确诊者的受检者甲状腺癌患病率显著更高,此类家族性水平的家系可能需要更密切的监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The actual rates of suspicious thyroid nodules (TNs) and confirmed thyroid cancer (TC) in putatively "at-risk" selected populations (e.g., individuals with family history of TC) are still uncertain. Methods: Our aim was to explore the prevalence of TC and TN in a cross-sectional study of a consenting population of unaffected individuals (10 years of age or older) with a first-degree relative known to have non-medullary TC (NMTC). Enrolled subjects underwent ultrasonographic studies of the neck between 2009 and 2018. Nodules considered suspicious according to current guidelines were subjected to fine-needle aspiration biopsy (FNAB) for cytology. Results: The screenee population comprised 1176 individuals (median age 42 [26-56] years, 650 females, 55.3%) from 473 kindreds (346 with 1 established NMTC diagnosis at entry, 103 with 2 established NMTC diagnoses, and 24 with 3 or more established NMTC diagnoses at entry). Screening revealed TNs in 500 screenees (42.5%; confidence interval [CI] 39.7-45.4%). Ninety-seven of these (19.4%; CI 16.2-23.1%) underwent FNAB. Only 11 cases of TC were diagnosed in the whole population (0.9%; CI 0.5-1.7%). The prevalence of TC in screenees from kindreds with ≥3 cases (3/24, 12.5%) was higher than that for kindreds with one affected member (6/346, 1.7%; p = 0.01, odds ratio [OR] 7.99; CI 1.21-40.75) and for those with two affected members (2/103, 1.9%; p = 0.05, OR 7.05; CI 0.76-89.44). The prevalence of TNs was 61.8% (CI 56.6-66.8%), 75.7% (CI 66.6-83%), and 66.7% (CI 46.7-82%) in the kindreds with 1, 2, and ≥3 cases, respectively (p = 0.03). Conclusions: On the whole, ultrasound-based screening of unaffected relatives of individuals with established diagnoses of NMTC is likely to reveal a high prevalence of TN and a low prevalence of TC. However, a significantly higher prevalence of TC may be found among screenees from kindreds with at least three established NMTC diagnoses before screening, suggesting that closer surveillance may be warranted in kindreds with this level of familiality.
引用
- Grani G, Lamartina L, Montesano T, et al. Prevalence of Thyroid Nodules and Thyroid Cancer in Individuals with a First-Degree Family History of Non-Medullary Thyroid Cancer: A Cross-Sectional Study Based on Sonographic Screening. Thyroid. 2022. PMID: 36097761. doi:10.1089/thy.2022.0253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。